10 May 2025

Last updated: Friday 9 May 2025

Research Directory

Developing radionuclide PARP inhibitors

The linker matters in antibody-drug conjugates

Real world evidence is changing regulatory policy

The hunt for the perfect tumour-associated antigen

New treatments for amyotrophic lateral sclerosis

Using wastewater surveillance to control Covid-19

Transatlantic partnerships in life science

The role of antibodies in Covid-19 treatment

Oncology approvals are on an upward trend

Finding a link between the microbiome and disease